Intellectual Property
Our DigiLum™ product is protected under an IP portfolio including internal innovations and externally licensed IP. Lumeda has secured a globally exclusive license to patents from Roswell Park Cancer Institute covering novel medical devices and light dosimetry methods used in the DigiLum™ system.
The company continues to generate patent applications, with recent patents issued covering optical devices, instrumentation, and machine-learning algorithms incorporated in the DigiLum™ system and its use in minimally invasive procedures and other settings.
| PATENT NUMBER | TITLE | ISSUE DATE |
| US 11,666,778 B2 | OPTICAL SURFACE APPLICATOR WITH INTEGRATED DIFFUSER | Jun. 6, 2023 |
| US 11,786,749 B2 | TIME MULTIPLEXED DOSIMETRY SYSTEM AND METHOD | Oct. 17, 2023 |
| US 11,801,395 B2 | OPTICAL APPLICATOR FEATURE OPTIMIZER | Oct. 31, 2023 |
| US 11,911,630 B1 | SMALL PROFILE LIGHT THERAPY PROBE | Feb. 27, 2024 |
| US 11,925,813 B1 | INTERSTITIAL PHOTODYNAMIC THERAPY PROBE DELIVERY DEVICE | Mar. 12, 2024 |
| US 11,925,814 B2 | OPTICAL APPLICATOR FEATURE OPTIMIZER | Mar. 12, 2024 |
| US 11,947,146 B2 | CONFIGURABLE OPTICAL APPLICATOR | Apr. 2, 2024 |
